|
|||||
|
|
Treatment optimization with secukinumab 150 mg for moderate‐to‐severe psoriasis in clinical practice: a single‐center open‐label 52‐week study |
|
| Authors: | Carlos Muñoz‐Santos MD PhD Joaquín Sola‐Ortigosa MD Antonio Guilabert MD PhD |
| Affiliation: | Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, Spain |
| Abstract: | |
| Keywords: | |